Suppr超能文献

转移性脊髓压迫症:放疗结果与剂量分割

Metastatic spinal cord compression: radiotherapy outcome and dose fractionation.

作者信息

Hoskin Peter J, Grover Amit, Bhana Rajanee

机构信息

Mount Vernon Centre for Cancer Treatment, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK.

出版信息

Radiother Oncol. 2003 Aug;68(2):175-80. doi: 10.1016/s0167-8140(03)00191-9.

Abstract

BACKGROUND AND PURPOSE

No standard dose fractionation has been defined for metastatic spinal cord compression. This retrospective analysis was undertaken to explore the impact of hypofractionated treatment compared to conventional multifraction treatment.

MATERIALS AND METHODS

One hundred and two consecutive patients referred to Mount Vernon Cancer Centre with metastatic spinal canal compression confirmed on MR scan in 95% with median age 68 years (range 32-90) and main primary tumour types breast (28%), prostate (28%) and lung (20%); 51% of patients were fully ambulant at diagnosis, 41% ambulant but with paraparesis and 9% had complete paraplegia. Spinal radiotherapy was given delivering a single dose in 32% and 20 Gy in five fractions in 64%.

RESULTS

The median survival was 3.5 months; survival was significantly related to primary site and motor function at presentation. Normal ambulation was achieved in 58% at 2 weeks and 71% up to 2 months after treatment. No patient who presented with paraplegia regained function. At presentation 59% of patients had severe pain, which fell to 8% at 2 weeks. Comparing those patients who received one or two dose treatments with those who received protracted fractionation, the two groups were matched for age, sex, primary site and site of compression. Relatively more patients treated with one or two doses had paraplegia; 19% vs. 3%. Despite this outcome in the two groups was equivalent for motor and sphincter function and pain control.

CONCLUSIONS

Metastatic spinal canal compression carries a poor prognosis. Urgent treatment will maintain and improve motor function in patients presenting ambulant but those who have paraplegia at presentation do not improve and have a very short survival. In this series no difference in outcome was seen between patients treated with one or two radiation doses compared to multifraction treatment; a randomised trial comparing fractionation schedules would be justified.

摘要

背景与目的

对于转移性脊髓压迫症,尚未确定标准的剂量分割方案。本回顾性分析旨在探讨与传统多分次治疗相比,大分割治疗的影响。

材料与方法

连续102例转诊至弗农山癌症中心的患者,经磁共振扫描确诊为转移性椎管压迫症,其中95%确诊,中位年龄68岁(范围32 - 90岁),主要原发肿瘤类型为乳腺癌(28%)、前列腺癌(28%)和肺癌(20%);51%的患者在诊断时可完全行走,41%可行走但有轻瘫,9%有完全性截瘫。32%的患者接受单次脊髓放疗,64%的患者接受5次分割、每次20 Gy的放疗。

结果

中位生存期为3.5个月;生存期与原发部位及就诊时的运动功能显著相关。治疗后2周时58%的患者恢复正常行走,至2个月时71%的患者恢复正常行走。截瘫患者无一恢复功能。就诊时59%的患者有严重疼痛,至2周时降至8%。将接受一或两次剂量治疗的患者与接受延长分割治疗的患者进行比较,两组在年龄、性别、原发部位和压迫部位方面相匹配。接受一或两次剂量治疗的患者中截瘫患者相对较多;分别为19%和3%。尽管如此,两组在运动和括约肌功能以及疼痛控制方面的结果相当。

结论

转移性椎管压迫症预后较差。紧急治疗可维持并改善可行走患者的运动功能,但就诊时即有截瘫的患者功能无改善且生存期极短。在本系列研究中,接受一或两次放射剂量治疗的患者与多分次治疗的患者在结局上无差异;比较分割方案的随机试验是合理的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验